VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price traded up 52.9% during trading on Thursday . The stock traded as high as C$0.15 and last traded at C$0.13. 1,350,857 shares traded hands during trading, an increase of 732% from the average session volume of 162,400 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Performance
The stock has a market cap of C$18.65 million, a P/E ratio of -3.55 and a beta of 0.39. The company has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.13. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- 3 Small Caps With Big Return Potential
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Comparing and Trading High PE Ratio Stocks
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
